IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -100.0% | 26 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $9,125,000 | +323.0% | 257,485 | +60.9% | 0.02% | +283.3% |
| Q1 2020 | $2,157,000 | -71.7% | 160,009 | -55.6% | 0.01% | -64.7% |
| Q4 2019 | $7,633,000 | +245.9% | 360,747 | +287.0% | 0.02% | +183.3% |
| Q2 2018 | $2,207,000 | +196.6% | 93,223 | +83.0% | 0.01% | +200.0% |
| Q1 2018 | $744,000 | -47.3% | 50,935 | -49.6% | 0.00% | -50.0% |
| Q3 2017 | $1,412,000 | +35200.0% | 100,997 | +5955.0% | 0.00% | – |
| Q2 2016 | $4,000 | – | 1,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |